Molecular quality control market is estimated to be valued at USD 337.2 Billion in 2031; 7.1% CAGR Projected- Coherent Market Insights

A newly published report by Coherent Market Insights reveals a sustainable growth in opportunities in the molecular quality control market.

Coherent Market Insights’ analyst projected the molecular quality control market to be valued at USD 337.2 Bn in 2031. It is expected to exhibit a CAGR of 7.1% over the forecast period 2024 -2031.

Market Dynamics:

Increasing adoption of molecular diagnostics technologies drives market growth. This is due to benefits such as high sensitivity and specificity.

Rising demand for external quality assessment programs also fuels market growth. Quality assessment is important for laboratories to monitor the performance and accuracy of molecular testing. Regulatory agencies such as the College of American Pathologists have mandatory requirements for clinical laboratories to enroll in an external quality assessment program. This is promoting the demand for quality control products.

Know the Latest Trends and Insights: https://www.coherentmarketinsights.com/market-insight/molecular-quality-control-market-2674

Market Trends:

Rise in customized quality control solutions is a key trend driving market growth. Vendors in are focusing on providing customized quality control solutions as per the application. This is expected to gain popularity over the forecast period.

Adoption of multiplex detection platforms is another trend gaining traction. Molecular diagnostic kits that can detect multiple targets are also gaining traction. This is expected to drive the demand for quality control products.

Molecular Quality Control Market Opportunities

Independent quality control testing segment is expected to hold the largest market share. It will account for around 35% of the total market share. These products are used to verify testing procedures carried out by clinical laboratories to ensure accuracy and reliability of results.

Single-analyte molecular quality controls check is expected to witness the fastest growth. The segment holds over 40% share. This is due to need for ensuring specificity of tests. Growing cases of chronic diseases will further boost demand for these controls.

Request free sample: https://www.coherentmarketinsights.com/insight/request-sample/2674

Key Market Takeaways

The Asia Pacific molecular quality control market is anticipated to witness a CAGR of 7.1% during the forecast period 2024-2031. This is due to increasing investments in healthcare infrastructure and expansion of clinical testing facilities.

On the basis of product type, independent quality control segment is expected to hold a dominant position. This is due to crucial needs for verification of testing accuracy without instrument dependencies.

On the basis of analyte type, single-analyte controls segment is expected to hold a dominant position over the forecast period. This is due to importance of ensuring specificity for conditions marked by expression of individual biomarkers.

On the basis of application, infectious disease diagnostics segment is anticipated to show fastest growth. This is due to leveraging controls for optimizing test sensitivities for fast-spreading viruses and bacteria.

North America is expected to hold a dominant position over the forecast period. This is due to well-established healthcare systems and frequent new product launches.

Competitor Insights

Key players operating in the molecular quality control market include:

Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Microbiologics, Inc.
ZeptoMetrix Corporation
Hoffmann-La Roche Ltd.
Abbott Laboratories
Quidel Corporation
Qnostics
Maine Molecular Quality Controls, Inc.

Recent Developments: 

On June 11, 2024, Bio-Rad Laboratories launched Exact Diagnostics GBS Positive and Negative Run Controls, expanding their molecular quality control range. These ready-to-use controls for Group B Streptococcus (GBS) molecular tests are intended to assess assay performance, operator proficiency, and workflow correctness.

ZeptoMetrix, introduced the SARS-CoV-2 Omicron Control in February 2022, adding to its range of infectious illness quality control solutions. The device, promotes trustworthy testing by targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mutations.

Interested to know the Market up Close. Buy the Full-report Now:

https://www.coherentmarketinsights.com/insight/buy-now/2674

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.